• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[严重中性粒细胞减少症中的感染:140例病例分析]

[Infection in severe neutropenia: analysis of 140 episodes].

作者信息

Gutiérrez J, Bronfman L, Lorca J, Pinto M E, Torrens M, Garcia M E, Barrientos A, Palma T

出版信息

Rev Med Chil. 1989 Oct;117(10):1141-9.

PMID:2519358
Abstract

We analyzed infections complicating 140 episodes of severe neutropenia in 86 patients. The underlying diagnosis was acute leukemia in 64, lymphoma in 12 and isolated cases of bone marrow aplasia, agranulocytosis, dysmyelopoiesis and solid tumors. No fever developed in 35 (25%) episodes. No cause for the fever was identified in 40% of the remaining episodes. Clinical evidence of an infection was present in 20%, with positive bacteriologic findings in 27%. Respiratory infection (16%), pneumonia (11%) and sepsis (10%) were the most common infectious processes. Infectious agents isolated were gram negative bacilli (72%), gram positive cocci (19%) and fungi (9%). The association of amikacin and carbenicillin or cephalosporins proved to be superior to gentamycin-penicillin (p less than 0.01). 16 patients died for an overall mortality of 11%. Pneumonia and infection by K pneumoniae or C albicans were associated to a poorer prognosis.

摘要

我们分析了86例患者中140次严重中性粒细胞减少症并发感染的情况。潜在诊断为急性白血病64例,淋巴瘤12例,以及骨髓再生障碍、粒细胞缺乏症、骨髓生成异常和实体瘤的孤立病例。35次(25%)发作未出现发热。其余发作中40%未发现发热原因。20%有感染的临床证据,27%有阳性细菌学检查结果。呼吸道感染(16%)、肺炎(11%)和败血症(10%)是最常见的感染过程。分离出的感染病原体为革兰氏阴性杆菌(72%)、革兰氏阳性球菌(19%)和真菌(9%)。阿米卡星与羧苄青霉素或头孢菌素联合使用被证明优于庆大霉素-青霉素(p<0.01)。16例患者死亡,总死亡率为11%。肺炎以及肺炎克雷伯菌或白色念珠菌感染与较差的预后相关。

相似文献

1
[Infection in severe neutropenia: analysis of 140 episodes].[严重中性粒细胞减少症中的感染:140例病例分析]
Rev Med Chil. 1989 Oct;117(10):1141-9.
2
[Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].亚胺培南/西司他丁与头孢他啶-阿米卡星治疗发热性中性粒细胞减少患者的对比研究
Rev Med Chil. 1995 Mar;123(3):312-20.
3
Febrile neutropenia in paediatric peripheral blood stem cell transplantation, in -vitro sensitivity data and clinical response to empirical antibiotic therapy.儿童外周血干细胞移植中的发热性中性粒细胞减少症、体外敏感性数据及对经验性抗生素治疗的临床反应
J Coll Physicians Surg Pak. 2006 Nov;16(11):704-8.
4
[Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].[循证医学概念在发热性中性粒细胞减少症治疗证据中的应用]
Enferm Infecc Microbiol Clin. 1999;17 Suppl 2:95-102.
5
Febrile neutropenia in cancer patients in a tertiary care medical center in Lebanon: microbial spectrum and outcome.黎巴嫩一家三级医疗中心癌症患者的发热性中性粒细胞减少症:微生物谱及预后
J Med Liban. 2000 May-Jun;48(3):136-42.
6
Empirical antimicrobial therapy in pediatric patients with neutropenia and fever. Risk factors for treatment failure.中性粒细胞减少和发热的儿科患者的经验性抗菌治疗。治疗失败的危险因素。
Arch Med Res. 1998 Winter;29(4):331-5.
7
[Empirical treatment of febrile episodes in patients with neutropenia in bone marrow transplantation].[骨髓移植中性粒细胞减少患者发热性发作的经验性治疗]
Enferm Infecc Microbiol Clin. 1990 Oct;8(8):490-5.
8
Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.头孢吡肟与美罗培南作为实体瘤患儿中性粒细胞减少和发热经验性单药治疗的比较
Pediatr Hematol Oncol. 2006 Apr-May;23(3):245-53. doi: 10.1080/08880010500506867.
9
[Bacterial septicemia in neutropenia patients].[中性粒细胞减少患者的细菌性败血症]
Ann Med Interne (Paris). 1983;134(7):629-35.
10
Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies.
Chemioterapia. 1988 Oct;7(5):330-5.